Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 7.875 7.50 8.25 7.875 7.875 7.88 21,282 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.0 -1.5 -0.5 - 30

Eden Research Share Discussion Threads

Showing 9401 to 9421 of 9850 messages
Chat Pages: Latest  382  381  380  379  378  377  376  375  374  373  372  371  Older
DateSubjectAuthorDiscuss
09/8/2020
12:39
Felt kinda compelled to post the Greece Mevalone link as I'm in Athens at the moment, K&NE outlet is based about 10 mins from the airport, I'm half tempted to pop in on the trip back and do some field research...like price ? comparison and how many cases have they ordered and do they expect it to fly of the shelf etc... I've had a couple of Kaiser Pilsners in the sun so apols if it doesn't make any sense to anybody else........
33mick
09/8/2020
11:47
Hi Mirandaj - You have worked a miracle - or else Eden are watching this thread and have just removed the glitch!! Knew it was a pdf file (I am using foxit) but did not respond this morning! 7995 above now edited!! AGM Q&A - interesting but well hedged!!
pugugly
09/8/2020
10:44
All the links on that page open perfectly well. It might be your computer PUGUGLY. pdf files
mirandaj
09/8/2020
10:22
Follow up to 7994 * The recent appointee came from Plant Health Care - However is this a plus point when the progess of the PHC share price is factored in? * Just been following up the Eden website https://www.edenresearch.com/investors/reports_and_presentations and neither 24/06/2020 AGM Questions and Answers nor 29/05/2020 2019 Annual Report will open when using standard click to open - Can anyone advise or is the site bust?? Edited -12:52pm Now working and opening OK Looks as though Mirandaj worked a miracle !!! * Not very encouraging that the combinded holing of the directors is 0.8% and current value of their combined holding is some £200,000 - Possibly less than some of the posters (or ex holders on this board) hold/held. However still looking at as appears to be in a very promising (ESG) sustainable area - OK maybe I should concentrate funds elsewhere as (e&oe) No UK agritech company has ever made real money for investors - either (imo) wrong products - scientific dead-end - not offering sufficient extra revenue to the users - or management lack sales skills or as the Yanks would say "The killer instinct"
pugugly
09/8/2020
10:00
Hi SS - Neither of the 2 above patent links refer to Eden - They appear on the face to have have had funding support from US Gov and to have been granted to University of Mass - What am I missing re Eden?
pugugly
08/8/2020
14:30
hTTps://www.efthymiadis.gr/default.aspx?lang=el-GR&page=447&prodid=1825 At some point you'd like to think sales will gain some traction.... Be nice if it ever gets UK approval...prob sat in some civil servants in tray collecting dust!
33mick
08/8/2020
13:50
You will not find facts just suppositions
chrischas
08/8/2020
12:46
Good afternoon PaulpaoloI have searched TT' website but found no reference to your post, even after following your link. TT's last updated their website in April of this year.Where can I read more on this story?Stay safe.
northwick
07/8/2020
19:14
Source? What are you referring too?
investingisatrickygame
07/8/2020
06:02
Wow verditek share price has almost doubled in a few days on news of sales... how unusual.. why don't you try that for some credibility EDEN, actually delivering rather that just paying yourselves handsomely when we're all having pay cuts.. disgraceful..
bjlk
06/8/2020
09:57
wan, re your post above 1069. Historically that statement may carry some merit and I think if everyone reviews properly we can all look back and see how things could have been managed better. The story has not been told, the opportunity has not been projected to be understood. Based on past performance we can see that would now have fallen flat. However, if Corteva proceeds as per the various RNS commentary and values that have been detailed, then management will get immediate credibility and so should the Company through its share price, regardless of management. Value will be in situ. If Eden is able to further add to this throughout this year or next and separate of Mevalone and Cedroz, then this should fully underpin value in the Company. Out of interest and being purely assumptive, if the Corteva contract proceeds on the annual values proposed, so €40 million/£35 million p.a., what P/E would you expect Eden to potentially trade on? Let's also be assumptive in that Mevalone and Cedroz sales will be paying for the operations of Eden Research Plc in full.
investingisatrickygame
05/8/2020
12:31
This stock and its management needs to be given a very wide berth, until at least they can conclusively prove they are up to the job and actually deliver for investors. Even the Chairman seems incapable of accurate commentary. Albeit, trust will take a long time to be earned given the history/track record!
wan
05/8/2020
11:44
Bottom line is Eden BOD has to get their finger out before it’s too late.Its being seen with Biochem Covid testing : you soon get market share taken when a new invention comes out.
chrischas
05/8/2020
11:34
erinvale5 Aug '20 - 09:47 - 7985 of 7985 0 3 0 Sales are key. Eden seem incapable of achieving real sales - they've had 25 years and are still touting authorisations as progress. The market is not that easily fooled. ----------------------------------------------------------------------------------- To be fair I don't think there's ANY interest in these currently. Any hot money has far warmer places to be; and nervous investors wouldn't be here. Today's RNS hardly makes the pulse race, but it is a sign of progress, albeit overdue. CED is larger than MEV; and of course we're also waiting upon the US to come through. All delayed due to COVID. Bottom line is, EDEN has more than enough cash for time being. And clock is ticking on seeds + Sustaine.
brucie5
05/8/2020
08:47
Sales are key. Eden seem incapable of achieving real sales - they've had 25 years and are still touting authorisations as progress. The market is not that easily fooled.
erinvale
05/8/2020
07:22
Unmentionable Sales.
supersonico
05/8/2020
07:21
Wow another approval, if only that is all companies had to do to be successful these days... WHAT ABOUT SALES???
bjlk
05/8/2020
06:14
New authorisation for Cedroz™ in Greece hTTps://polaris.brighterir.com/public/eden_research/news/rns/story/x5ol62r
supersonico
04/8/2020
08:10
I note that yesterday Bayer completed the sale of its Animal Health business unit to Elanco. Readers will recall that in a recent amendment to the agreement, it was agreed that if for any reason Bayer does not advance the project, both parties have agreed that all elements of the intellectual property and know-how will transfer to Eden, including formulations, clinical and marketing data, market research, business plans, the associated brands and trademarks, and other information relating to the project. Is that a boomerang on the horizon?
wan
04/8/2020
06:48
Wow all we need now is some sales.
chrischas
03/8/2020
17:47
Unmentionable US patent. No 1 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS hTTp://www.freepatentsonline.com/WO2019178443A1.pdf Unmentionable US patent. No 2 COMPOSITIONS CONTAINING A HOLLOW GLUCAN PARTICLE OR A CELL WALL PARTICLE ENCAPSULATING A TERPENE COMPONENT, METHODS OF MAKING AND USING THEM hTTp://www.freepatentsonline.com/20200236927.pdf
supersonico
Chat Pages: Latest  382  381  380  379  378  377  376  375  374  373  372  371  Older
ADVFN Advertorial
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201201 15:13:33